Dr. Nagourney's Blog


Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

For Some Cancer Patients, A Bad Gene Can Be A Good Gene
By Robert A. Nagourney, MD
Ironically, many of the worst cancers prove to be the easiest to treat when new discoveries are made. Hairy cell leukemia, once the bane of hematologists, is now cured with a single course of 2-CdA. Chronic myelogenous leukemia (CML),...
Complete Response in Triple Negative Breast Cancer Treatment
By Robert A. Nagourney, MD
Triple negative breast cancer (TNBC) represents a distinct form of breast cancer that does not express estrogen receptors (ER),...
Breast Cancer-Same Age, Same Diagnosis, Different Functional Profiles
By Robert A. Nagourney, MD
A day in the life of advanced breast cancer. Two different 37-year-old breast cancer patients, both mothers of young children,...
Triple Negative Breast Cancer - Worse or Just Different?
By Robert A. Nagourney, MD
The term “triple negative breast cancer” (TNBC) is applied to a subtype of breast cancers that do not express the estrogen or...
Rare Tumors - Challenges and Triumphs
By Robert A. Nagourney, MD
When I am asked how our EVA-PCD laboratory platform might best be applied, I have several responses. On the one hand, there is...
Do We Already Have the Tools We Need to Cure Cancer?
By Robert A. Nagourney, MD
The rapid-fire sequence of the annual American Association of Cancer Research (AACR) meeting, held in May, followed by the...
PARP Inhibitors in Breast Cancer? What happened?
By Robert A. Nagourney, MD
Many of you may recall that we described our studies with the small molecules BSI201 (iniparib) and AZD2281 (olaparib)...

browse by topic

Select A topic

View All Topics

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.